| 中文名 | AS 2444697,IRAK4抑制剂 |
|---|---|
| 英文名 | AS2444697 |
| 中文别名 | N-[3-氨基羰基)-1-(四氢-2H-吡喃-4-基)-1H-吡唑-4-基]-2-(2-甲基-4-吡啶基)-4-恶唑酰胺盐酸盐 |
| 英文别名 |
AS-244469
AS-2444697 HCl IL-1R associated kinase,IRAK-4,anti-inflammatory,IRAK,AS-2444697,inhibit,AS2444697,AS 2444697,renoprotective,Inhibitor,Interleukin-1 rector associated kinase AS-2444697 N-[3-Carbamoyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide hydrochloride (1:1) N-[3-Carbamoyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide AS-2444697, 10 mM in DMSO N-[3-Aminocbonyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-4-oxazolecboxamide hydrochloride AS-2444697 HC MFCD30182294 4-Oxazolecboxamide, N-[3-(aminocbonyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-, hydrochloride (1:1) 4-Oxazolecarboxamide, N-[3-(aminocarbonyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-, hydrochloride (1:1) N-(3-CBAMOYL-1-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-PYRAZOL-4-YL)-2-(2-METHYLPYRIDIN-4-YL)OXAZOLE-4-CBOXAMIDE HCL N-(3-cbamoyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)-2-(2-methylpyridin-4-yl)oxazole-4-cboxamide hydrochloride AS2444697 >= (HPLC) N-[3-(Aminocarbonyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl-2-(2-methyl-4-pyridinyl)-4-Oxazolecarboxamide hydrochloride (1:1) AS-2444697 (hydrochloride) |
| 描述 | 一种有效的,选择性的,口服生物可利用的IRAK-4抑制剂,以亚纳摩尔顺序有效抑制人和大鼠IRAK-4活性,对IRAK-1的选择性>30倍;抑制IL-1β或TLR配体脂多糖(LPS)诱导人肺泡上皮细胞,成纤维细胞样滑膜细胞中IL-6的产生,和外周血单核细胞;显着减少尿蛋白排泄,预防肾小球硬化和间质纤维化的发展,而不影响慢性肾病小鼠模型的血压。 |
|---|---|
| 参考文献 | References 1. Kondo M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct;387(10):909-19. 2. Imanishi J, et al. Arthritis Rheum 63:S390. View Related Products by Target IRAK |
| 分子式 | C19H21ClN6O4 |
|---|---|
| 分子量 | 432.861 |
| 精确质量 | 432.131287 |
| 储存条件 | 室温,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|